Zobrazeno 1 - 10 of 331 pro vyhledávání: '"Guelman S"'
1
Akademický článek
Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development.
Autor: Hays A; BioAgilytix Laboratories, Durham, North Carolina, USA. amanda.hays@bioagilytix.com., Wissel M; Eurofins Viracor BioPharma Services, Inc., Lenexa, Kansas, USA., Colletti K; Beam Therapeutics, Cambridge, Massachusetts, USA., Soon R; BioMarin Pharmaceutical Inc., Novato, California, USA., Azadeh M; Ultragenyx Pharmaceutical Inc., Novato, Calfornia, USA., Smith J; Pfizer Inc, Groton, Connecticut, USA., Doddareddy R; Merck & Co., Inc., Rahway, New Jersey, USA., Chalfant M; GSK, Collegeville, Pennsylvania, USA., Adamowicz W; PPD Clinical Research, Thermo Fisher Scientific, Richmond, Virginia, USA., Ramaswamy SS; Eli Lilly and Company, Indianapolis, Indiana, USA., Dholakiya SL; Bristol Myers Squibb, Princeton, New Jersey, USA., Guelman S; Genentech, Inc., South San Francisco, California, USA., Gullick B; BioAgilytix Laboratories, Durham, North Carolina, USA., Durham J; BioAgilytix Laboratories, Boston, Massachusetts, USA., Rennier K; Labcorp Drug Development, Greenfield, Indiana, USA., Nagilla P; Asher Biotherapeutics, Inc., South San Francisco, California, USA., Muruganandham A; BioAgilytix Laboratories, Durham, North Carolina, USA., Diaz M; Eurofins Viracor BioPharma Services, Inc., Lenexa, Kansas, USA., Tierney C; Pfizer Inc, Groton, Connecticut, USA., John K; REGENXBIO Inc., Rockville, Maryland, USA., Valentine J; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Lockman T; PPD Clinical Research, Thermo Fisher Scientific, Richmond, Virginia, USA., Liu HY; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Moritz B; Charles River Labs, Reno, Nevada, USA., Ouedraogo JP; Charles River Labs, Senneville, Québec, Canada., Piche MS; Charles River Labs, Senneville, Québec, Canada., Smet M; Sanofi, Ghent, Belgium., Murphy J; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Koenig K; Altasciences Preclinical Seattle LLC, Everett, Washington, USA., Zybura A; Labcorp Drug Development, Greenfield, Indiana, USA., Vyhlidal C; KCAS Bioanalytical and Biomarker Services, Shawnee, Kansas, USA., Mercier J; Flowmetric Life Sciences, Inc., Spring House, Pennsylvania, USA., Jani N; BioAgilytix Laboratories, Boston, Massachusetts, USA., Kubista M; Institute of Biotechnology Czech Academy of Sciences, Prague, Czech Republic., Birch D; Altasciences Preclinical Seattle LLC, Everett, Washington, USA., Morse K; Altasciences Preclinical Seattle LLC, Everett, Washington, USA., Johansson O; TATAA Biocenter, Gothenburg, Sweden.
Publikováno v: The AAPS journal [AAPS J] 2024 Feb 05; Vol. 26 (1), pp. 24. Date of Electronic Publication: 2024 Feb 05.
Zobrazit plný text záznamu
2
Correction to: Preclinical development of ZED8, an 89 Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.
Autor: Ogasawara A; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Kiefer JR; Department of Structural Biology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Gill H; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Chiang E; Department of Cancer Immunology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Sriraman S; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Ferl GZ; Preclinical and Translational Pharmacokinetics, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Ziai J; Research Pathology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Bohorquez SS; Oncology Exploratory Clinical Development, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Guelman S; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Wang X; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Yang J; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Phan MM; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Nguyen V; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Chung S; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Yu C; Department of Structural Biology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Tinianow J; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Waaijer SJH; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., De Crespigny A; Oncology Exploratory Clinical Development, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Marik J; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Boswell CA; Preclinical and Translational Pharmacokinetics, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Zabka T; Safety Assessment Pathology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Staflin K; Safety Assessment Toxicology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Williams SP; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. williams.simon@gene.com.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jan; Vol. 50 (2), pp. 631.
Zobrazit plný text záznamu
3
Akademický článek
Preclinical development of ZED8, an 89 Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.
Autor: Ogasawara A; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Kiefer JR; Department of Structural Biology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Gill H; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Chiang E; Department of Cancer Immunology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Sriraman S; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Ferl GZ; Preclinical and Translational Pharmacokinetics, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Ziai J; Research Pathology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Bohorquez SS; Oncology Exploratory Clinical Development, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Guelman S; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Wang X; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Yang J; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Phan MM; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Nguyen V; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Chung S; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Yu C; Department of Structural Biology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Tinianow J; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Waaijer SJH; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., De Crespigny A; Oncology Exploratory Clinical Development, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Marik J; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Boswell CA; Preclinical and Translational Pharmacokinetics, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Zabka T; Safety Assessment Pathology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Staflin K; Safety Assessment Toxicology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA., Williams SP; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. williams.simon@gene.com.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jan; Vol. 50 (2), pp. 287-301. Date of Electronic Publication: 2022 Oct 22.
Zobrazit plný text záznamu
4
Akademický článek
Whole-body CD8 + T cell visualization before and during cancer immunotherapy: a phase 1/2 trial.
Autor: Kist de Ruijter L; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van de Donk PP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Giesen D; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Lub-de Hooge MN; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Timens W; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Brouwers AH; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kwee TC; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Fine BM; Genentech Inc., South San Francisco, CA, USA., Sanabria Bohórquez SM; Genentech Inc., South San Francisco, CA, USA., Yadav M; Genentech Inc., South San Francisco, CA, USA., Koeppen H; Genentech Inc., South San Francisco, CA, USA., Jing J; Genentech Inc., South San Francisco, CA, USA., Guelman S; Genentech Inc., South San Francisco, CA, USA., Lin MT; Genentech Inc., South San Francisco, CA, USA., Mamounas MJ; Genentech Inc., South San Francisco, CA, USA., Eastham JR; Genentech Inc., South San Francisco, CA, USA., Kimes PK; Genentech Inc., South San Francisco, CA, USA., Williams SP; Genentech Inc., South San Francisco, CA, USA., Ungewickell A; Genentech Inc., South San Francisco, CA, USA., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. e.g.e.de.vries@umcg.nl.
Publikováno v: Nature medicine [Nat Med] 2022 Dec; Vol. 28 (12), pp. 2601-2610. Date of Electronic Publication: 2022 Dec 05.
Zobrazit plný text záznamu
5
Akademický článek
Clinical Pharmacology Perspectives for Adoptive Cell Therapies in Oncology.
Autor: Huang W; Genentech Inc., South San Francisco, California, USA., Li J; Genentech Inc., South San Francisco, California, USA., Liao MZ; Genentech Inc., South San Francisco, California, USA., Liu SN; Genentech Inc., South San Francisco, California, USA., Yu J; Genentech Inc., South San Francisco, California, USA., Jing J; Genentech Inc., South San Francisco, California, USA., Kotani N; Genentech Inc., South San Francisco, California, USA.; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Kamen L; Genentech Inc., South San Francisco, California, USA., Guelman S; Genentech Inc., South San Francisco, California, USA., Miles DR; Genentech Inc., South San Francisco, California, USA.
Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Nov; Vol. 112 (5), pp. 968-981. Date of Electronic Publication: 2022 Jan 21.
Zobrazit plný text záznamu
6
Akademický článek
A Fit-for-Purpose Method to Measure Circulating Levels of the mRNA Component of a Liposomal-Formulated Individualized Neoantigen-Specific Therapy for Cancer.
Autor: Guelman S; Department of BioAnalytical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080-4990, USA. sguelman@gene.com., Zhou Y; Department of BioAnalytical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080-4990, USA., Brady A; Department of BioAnalytical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080-4990, USA., Peng K; Department of BioAnalytical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080-4990, USA.
Publikováno v: The AAPS journal [AAPS J] 2022 May 02; Vol. 24 (3), pp. 64. Date of Electronic Publication: 2022 May 02.
Zobrazit plný text záznamu
7
Akademický článek
Human dose-escalation study of PET imaging CD8 + T-cell infiltration in solid malignancies with [ 68 Ga]Ga -NODAGA-SNA006.
Autor: Wang Y; Department of Clinical Pharmacology, First Affiliated Hospital of Soochow University, Suzhou, China.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Zheng M; Department of Clinical Pharmacology, First Affiliated Hospital of Soochow University, Suzhou, China.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Zhao J; Department of Thoracic Surgery, First Affiliated Hospital of Soochow University, Suzhou, China., Wang C; Smart-Nuclide Biotech, No. 218 Xing-Hu Rd, Suzhou, Jiangsu, 215125, China., Zhao S; Department of Clinical Pharmacology, First Affiliated Hospital of Soochow University, Suzhou, China.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Bian Y; Department of Clinical Pharmacology, First Affiliated Hospital of Soochow University, Suzhou, China.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Dai N; Department of Nuclear Medicine, First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Zheng Y; Department of Pathology, First Affiliated Hospital of Soochow University, Suzhou, China., Sang S; Department of Nuclear Medicine, First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Guo L; Department of Pathology, First Affiliated Hospital of Soochow University, Suzhou, China., Huang C; Department of Clinical Pharmacology, First Affiliated Hospital of Soochow University, Suzhou, China.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Zhang H; Department of Clinical Pharmacology, First Affiliated Hospital of Soochow University, Suzhou, China.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Jiang J; Department of Nuclear Medicine, First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Xu C; Department of Thoracic Surgery, First Affiliated Hospital of Soochow University, Suzhou, China., Zhao Q; Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou, China., Han J; Department of Thoracic Surgery, First Affiliated Hospital of Soochow University, Suzhou, China., Xu T; Smart-Nuclide Biotech, No. 218 Xing-Hu Rd, Suzhou, Jiangsu, 215125, China. tao.xu@smartnucl.com., Qin S; Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou, China. qin92244@163.com.; First Affiliated Hospital of Soochow University, No. 899 Ping-Hai Rd, Suzhou, Jiangsu, 215006, China. qin92244@163.com., Miao L; Department of Clinical Pharmacology, First Affiliated Hospital of Soochow University, Suzhou, China. miaolysuzhou@163.com.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China. miaolysuzhou@163.com.; First Affiliated Hospital of Soochow University, No. 899 Ping-Hai Rd, Suzhou, Jiangsu, 215006, China. miaolysuzhou@163.com.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Dec 10. Date of Electronic Publication: 2024 Dec 10.
Zobrazit plný text záznamu
8
Akademický článek
Treating Tissue Factor-Positive Cancers with Antibody-Drug Conjugates That Do Not Affect Blood Clotting.
Autor: Theunissen JW; Iconic Therapeutics, South San Francisco, California. jtheunissen@iconictherapeutics.com., Cai AG; Iconic Therapeutics, South San Francisco, California., Bhatti MM; Iconic Therapeutics, South San Francisco, California., Cooper AB; Adimab, Lebanon, New Hampshire., Avery AD; Adimab, Lebanon, New Hampshire., Dorfman R; Haematologic Technologies, Essex Junction, Vermont., Guelman S; Iconic Therapeutics, South San Francisco, California., Levashova Z; Iconic Therapeutics, South San Francisco, California., Migone TS; Iconic Therapeutics, South San Francisco, California.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2018 Nov; Vol. 17 (11), pp. 2412-2426. Date of Electronic Publication: 2018 Aug 20.
Zobrazit plný text záznamu
9
Akademický článek
Knockout mice with pituitary malformations help identify human cases of hypopituitarism.
Autor: Martinez-Mayer, Julian1 (AUTHOR), Brinkmeier, Michelle L.2 (AUTHOR), O'Connell, Sean P.3 (AUTHOR), Ukagwu, Arnold4 (AUTHOR), Marti, Marcelo A.5 (AUTHOR), Miras, Mirta6 (AUTHOR), Forclaz, Maria V.7 (AUTHOR), Benzrihen, Maria G.7 (AUTHOR), Cheung, Leonard Y. M.2,8 (AUTHOR), Camper, Sally A.2 (AUTHOR), Ellsworth, Buffy S.4 (AUTHOR), Raetzman, Lori T.9 (AUTHOR), Pérez-Millán, Maria I.1 (AUTHOR) mipmillan@gmail.com, Davis, Shannon W.3 (AUTHOR) swdavis@mailbox.sc.edu
Publikováno v: Genome Medicine. 5/31/2024, Vol. 16 Issue 1, p1-24. 24p.
Zobrazit plný text záznamu
10
Akademický článek
Silencing of HMW glutenins in transgenic wheat expressing extra HMW subunits.
Autor: Alvarez, M. L., Guelman, S., Halford, N. G., Lustig, S., Reggiardo, M. I., Ryabushkina, N., Schewry, P., Stein, J., Vallejos, R. H.
Publikováno v: Theoretical & Applied Genetics; Jan2000, Vol. 100 Issue 2, p319-327, 9p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje